Lobectomy versus stereotactic body radiotherapy in healthy patients with stage i lung cancer

Journal of Thoracic and Cardiovascular Surgery

Volumn 152, Issue 1, 2016, Pages 44-54.e9

  Rosen, Joshua E ^a   Salazar, Michelle C ^a   Wang, Zuoheng ^b   Yu, James B ^a   Decker, Roy H ^a   Kim, Anthony W ^a   Detterbeck, Frank C ^a   Boffa, Daniel J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

lobectomy; lung cancer; NSCLC; SBRT; stereotactic body radiotherapy; survival

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; STEREOTACTIC BODY RADIATION THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; LUNG NEOPLASMS; LUNG RESECTION; MORTALITY; PATHOLOGY; RADIOSURGERY; SURVIVAL RATE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; RADIOSURGERY; SURVIVAL RATE;

EID: 84964621995     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2016.03.060     Document Type: Article

References (35)

1. American Cancer Society Cancer Facts and Figures 2015 2015 American Cancer Society Atlanta, GA
2. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 623
3. S. Stanic, R. Paulus, R.D. Timmerman, J.M. Michalski, R.B. Barriger, A. Bezjak, and et al. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 Int J Radiat Oncol Biol Phys 88 2014 1092 1099
4. T.D. Crabtree, C.E. Denlinger, B.F. Meyers, I. Naqa El, J. Zoole, A.S. Krupnick, and et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
5. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, J. Bradley, and et al. Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
6. I.S. Grills, V.S. Mangona, R. Welsh, G. Chmielewski, E. McInerney, S. Martin, and et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
7. F.J. Lagerwaard, N.E. Verstegen, C.J. Haasbeek, B.J. Slotman, M.A. Paul, E.F. Smit, and et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
8. N.E. Verstegen, J.W. Oosterhuis, D.A. Palma, G. Rodrigues, F.J. Lagerwaard, A. van der Elst, and et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis Ann Oncol 24 2013 1543 1548
9. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, K. Gomi, and et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
10. M. van Rens, and A.B. la Riviere de Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA Chest 117 2000 374 379
11. K. Yamamoto, A. Ohsumi, F. Kojima, N. Imanishi, K. Matsuoka, M. Ueda, and et al. Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer Ann Thorac Surg 89 2010 353 359
12. J.Y. Chang, S. Senan, M.A. Paul, R.J. Mehran, A.V. Louie, P. Balter, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 2015 630 637
13. V. Puri, T.D. Crabtree, J.M. Bell, S.R. Broderick, D. Morgensztern, G.A. Colditz, and et al. Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy J Thorac Oncol 10 2015 1776 1784
14. N. Howlader, A.B. Mariotto, S. Woloshin, and L.M. Schwartz Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death J Natl Cancer Inst Monographs 2014 2014 255 264
15. S. Mokhles, J.J. Nuyttens, A.P. Maat, O. Birim, J.G.J.V. Aerts, A.J.J.C. Bogers, and et al. Survival and treatment of non-small cell lung cancer stage I-II treated surgically or with stereotactic body radiotherapy: patient and tumor-specific factors affect the prognosis Ann Surg Oncol 22 2015 316 323
16. S.M. Shirvani, J. Jiang, J.Y. Chang, J.W. Welsh, D.R. Gomez, S. Swisher, and et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 2012 1060 1070
17. J.B. Yu, P.R. Soulos, L.D. Cramer, R.H. Decker, A.W. Kim, and C.P. Gross Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer Cancer 121 2015 2341 2349
18. J.E. Rosen, J.G. Hancock, A.W. Kim, F.C. Detterbeck, and D.J. Boffa Predictors of mortality after surgical management of lung cancer in the National Cancer Database Ann Thorac Surg 98 2014 1953 1960
19. American College of Surgeons Commission on Cancer. Cancer program standards 2012: ensuring patient-centered care 2011 American College of Surgeons Chicago, IL Available at: https://www.facs.org/∼/media/files/quality%20programs/cancer/coc/programstandards2012.ashx.
20. American College of Surgeons. The National Cancer Database 2013 PUF Data Dictionary. 2011. Available at: http://ncdbpuf.facs.org/node/259. Accessed July 1, 2015.
21. B.P. Rowe, D.J. Boffa, L.D. Wilson, A.W. Kim, F.C. Detterbeck, and R.H. Decker Stereotactic body radiotherapy for central lung tumors J Thorac Oncol 7 2012 1394 1399
22. C.D. Corso, H.S. Park, A.W. Kim, J.B. Yu, Z. Husain, and R.H. Decker Racial disparities in the use of SBRT for treating early-stage lung cancer Lung Cancer 89 2015 133 138
23. I.S. Grills, A.J. Hope, M. Guckenberger, L.L. Kestin, M. Werner-Wasik, D. Yan, and et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393
24. S.L. Edwards, C. Roberts, M.E. McKean, J.S. Cockburn, R.R. Jeffrey, and K.M. Kerr Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category J Clin Pathol 53 2000 537 540
25. J. Cataluna, M. Perpina, and J.V. Greses Cell type accuracy of bronchial biopsy specimens in primary lung cancer Chest 109 1996 1199 1203
26. J.S. Haukoos, and R.J. Lewis The propensity score JAMA 314 2015 1637 1638
27. D.J. Boffa, A.S. Kosinski, S. Paul, J.D. Mitchell, and M. Onaitis Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections Ann Thorac Surg 94 2012 347 353
28. R. Arriagada, B. Bergman, A. Dunant, T. Le Chevalier, J.-P. Pignon, J. Vansteenkiste, and et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351 360
29. J.-P. Pignon, H. Tribodet, G.V. Scagliotti, J.-Y. Douillard, F.A. Shepherd, R.J. Stephens, and et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
30. J.G. Hancock, J.E. Rosen, A. Antonicelli, A. Moreno, A.W. Kim, F.C. Detterbeck, and et al. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery Ann Thorac Surg 99 2015 406 413
31. G.M. Strauss, J.E. Herndon, M.A. Maddaus, D.W. Johnstone, E.A. Johnson, D.H. Harpole, and et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups J Clin Oncol 26 2008 5043 5051
32. X. Zheng, M. Schipper, K. Kidwell, J. Lin, R. Reddy, Y. Ren, and et al. Survival outcome after stereotactic body radiation therapy and surgery for stage I non-small cell lung cancer: a meta-analysis Int J Radiat Oncol Biol Phys 90 2014 603 611
33. R.D. Timmerman, R. Paulus, and H.I. Pass RTOG 0618: Stereotactic body radiation therapy (SBRT) to treat operable early-stage lung cancer patients J Clin Oncol 21 2013 suppl abstr 7523
34. J.-Y. Douillard, H. Tribodet, D. Aubert, F.A. Shepherd, R. Rosell, K. Ding, and et al. Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation J Thorac Oncol 5 2010 220 228
35. G.A. Silvestri, A.V. Gonzalez, M.A. Jantz, M.L. Margolis, M.K. Gould, L.T. Tanoue, and et al. Methods for Staging Non-small Cell Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 143 2013 E211 E250